A formulation comprises a plurality of seamless minicapsules, the minicapsules having a diameter of from 0.5 mm to 5 mm, the minicapsules having a core containing an active entity and an encapsulating body, the active entity being in the form of any one or more of:-
• a microemulsion,
• a nanoemulsion,
• a self-emulsifying delivery system,
• a self-microemulsifying delivery system,
• a biostable perflurocarbon formulation,
• a complex with cyclodextrin (and the like),
• liposomes,
• hydrogel,
• lymphatic targeted delivery system,
• liquid bi-layers,
• an aqueous system,
• wax,
• emzaloid, and
• natural plant extract.
一种制剂包括多个无缝微型胶囊,微型胶囊的直径为 0.5 毫米至 5 毫米,微型胶囊有一个含有活性实体的核心和一个封装体,活性实体的形式为以下任何一种或多种: - 微乳剂
- 微乳剂
- 纳米乳液
- 自乳化给药系统
- 自微乳化给药系统、
-
生物稳定的过
氟碳制剂、
- 与
环糊精的复合物(等)、
- 脂质体
-
水凝胶
- 淋巴定向给药系统、
- 液体双层
-
水性系统、
- 蜡
- emzaloid,以及
- 天然
植物提取物。